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ABSTRACT
Аryl hydrocarbon receptor (AHR) is the key transcription factor that controls 
animal development and various adaptive processes. The AHR’s target genes are 
involved in biodegradation of endogenous and exogenous toxins, regulation of 
immune response, organogenesis, and neurogenesis. Ligand binding is important 
for the activation of the AHR signaling pathway. Invertebrate AHR homologs are 
activated by endogenous ligands whereas vertebrate AHR can be activated by both 
endogenous and exogenous ligands (xenobiotics). Several studies using mammalian 
cultured cells have demonstrated that transcription of the AHR target genes can be 
activated by exogenous AHR ligands, but little is known about the effects of AHR 
in a living organism. Here, we examined the effects of human AHR and its ligands 
using transgenic Drosophila lines with an inducible human AhR gene. We found 
that exogenous AHR ligands can increase as well as decrease the transcription 
levels of the AHR target genes, including genes that control proliferation, motility, 
polarization, and programmed cell death. This suggests that AHR activation may 
affect the expression of gene networks that could be critical for cancer progression 
and metastasis. Importantly, we found that AHR target genes are also controlled 
by the enzymes that modify chromatin structure, in particular components of the 
epigenetic Polycomb Repressive complexes 1 and 2. Since exogenous AHR ligands 
(alternatively – xenobiotics) and small molecule inhibitors of epigenetic modifiers 
are often used as pharmaceutical anticancer drugs, our findings may have significant 
implications in designing new combinations of therapeutic treatments for oncological 
diseases.
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INTRODUCTION
Many cellular processes in higher multicellular 
organisms depend on the activity of the Aryl hydrocarbon 
receptor (AHR); among them are the maintenance 
of homeostasis, the regulation of detoxification, cell 
division, differentiation, polarization, programmed cell 
death, the formation of organ-tissue structures, nervous, 
immune, cardiovascular, endocrine, generative, and 
excretory systems [1–14]. AHR is a transcription factor 
with three functional domains: a highly conserved 
N-terminal basic-helix-loop-helix (bHLH) domain, a less 
conserved Per/Arnt/Sim (PAS) domain, and a weakly 
conserved C-terminal domain [6, 15]. Unliganded human 
AHR is localized in the cytoplasm where it is associated 
with the molecular chaperons HSP90 (Heat Shock 
Protein 90) and XAP2/AIP (X-associated protein 2/AhR-
interacting protein). Following binding to the ligand, AHR 
translocates to the nucleus, dissociates from HSP90, forms 
a heterodimer with the ARNT (Aryl hydrocarbon receptor 
nuclear translocator) and binds to specific DNA sequences 
known as the Xenobiotic Response Elements.
In humans and mammals, AHR is activated by a 
variety of endogenous ligands and xenobiotics (exogenous 
ligands) [16–19]. While maintenance of a proper 
concentration of the active (liganded) AHR is important 
for cell survival and organism functioning [20–24], the 
changes in AHR expression are rather frequent events. For 
example, aging is often associated with a decrease in the 
level of AHR expression. The most dramatic consequences 
of the decreased AHR expression are an increased risk of 
cancer and the inability to protect cells against the toxic 
effects of xenobiotics [25, 26]. Ectopic AHR activation 
causes a variety of developmental disorders, e.g., 
abnormal organogenesis and histogenesis, disruptions 
in the nervous, immune, cardiovascular, endocrine, 
and generative systems. In humans and vertebrates, 
the endogenous ligands often function as agonists that 
enhance AHR activity. There is a wide range of affinities 
of xenobiotic ligands to AHR [27]. Apparently, the ligand 
binding affinities can modulate AHR’s ability to activate 
target genes [28]. 
Experiments in cultured cells limit the understanding 
of the effects induced by the AHR expression on the 
developmental processes in the living organism. To 
gain a better understanding of the functioning of AHR 
in vivo, we created several ‘humanized’ Drosophila 
transgenic animals, which carry transgenes with the 
inducible human AhR gene under the control of the yeast 
UAS (Upstream Activation Sequence) promoter element. 
These transgenic constructs allow the induction of AHR 
expression in different organs of Drosophila by using 
various tissue-specific GAL4-drivers [29]. It is believed 
that in invertebrates, AHR homologs are activated only by 
endogenous ligands [4, 30]. Therefore, since the majority 
of xenobiotics activating human AHR are not able to 
activate the Drosophila AHR homolog, this allows the 
assessment of their specificity of action by introducing 
them into the Drosophila feed medium. Activation of the 
human AHR in different Drosophila tissues and organs 
allows us to estimate the ability of the human AHR ligands 
to regulate transcription of the human AHR target genes 
in vivo. It was previously shown that transgenic mouse 
AHR and Drosophila ARNT could form a functional 
heterodimer capable of inducing dioxin-mediated 
activation of AHR target gene homologs in Drosophila 
[31]. Here, we demonstrated that AHR activation induced 
by different exogenous ligands has pleiotropic effects, i.e. 
it can both increase and decrease transcription of the AHR 
target genes in different tissues and this effect depends on 
the developmental stage of the animal. Importantly, we 
found that AHR’s effect on target genes is mediated by 
Polycomb group (PcG) epigenetic chromatin regulators. 
Thus, the results of this study expand our knowledge 
of the in vivo role of the human AHR in the regulation 
of development and biodegradation of the toxic agents 
and opens up the possibility of using combinations of 
xenobiotics and epigenetic inhibitors in the treatment of 
a variety of diseases. 
RESULTS
Strong phenotypic effects of endogenous and 
exogenous human AHR ligands in Drosophila 
tissues 
It is essential to study the effects of xenobiotics on 
mammalian AHR in vivo. Drosophila represents a unique 
model for these experiments since previous studies have 
indicated that dioxin and other xenobiotics, which are 
known to bind to the mammalian AHR, were unable to 
activate the invertebrate AHR homologue. However, 
dioxin affected Drosophila leg and eye development 
when the ectopic mouse UAS-AhR was induced by the 
dpp-GAL4 and GMR-GAL4 drivers in the primordial leg 
or eye tissues, respectively [31]. At the same time, it is 
possible that there are some endogenous ligands that are 
capable of activating human AHR in other Drosophila 
tissues. To investigate this we used a number of GAL4 
driver lines to induce human AHR in different Drosophila 
tissues. Ubiquitous expression of the UAS-AhR transgene 
by tub-GAL4 and Act-GAL4 drivers resulted in embryonic 
lethality. Only a few individuals survived to the larval 
development stage (Figure 1A). This confirms the 
existence of endogenous ligands that can affect the human 
AHR activity in Drosophila. Further, the induction of 
UAS-AhR expression by the Dll-GAL4 driver caused 
complete lethality of the Drosophila pupae, as no adults 
could hatch. Examination of the leg morphology of the 
unhatched animals confirmed the complete malformation 
of the distal leg segments; tarsal segments were missing or 
severely malformed (Figure 1B–1C).
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Interestingly, the effects of the endogenous ligands 
on the human AHR are limited to a few tissues, as 
induction of UAS-AhR ectopic expression by the dpp-
GAL4 driver (without exogenous ligands) only partially 
affected wing development (Figure 1H). However, feeding 
of animals with the exogenous ligands exacerbated the 
abnormal wing phenotype (Figure 1I) and caused strong 
leg deformities (Figure 1D–1F). These leg defects were 
similar to those caused by the ectopic expression of mouse 
UAS-AhR induced by the dpp-GAL4 driver in Drosophila 
larvae fed with dioxin [31].
Induction of UAS-AhR expression in the female 
germ line with an MTD-gal4 driver, combined 
with exposure of MTD-GAL4/UAS-AhR flies to the 
exogenous ligands, resulted in a wide range of different 
abnormalities during oogenesis. The ovary of the wild-
type Drosophila consists of egg tubes called ovarioles 
(Figure 2A). The oocyte develops within a group of cells 
known as an egg chamber (or follicle), which consists of 
a cluster (or cyst) of 16 germ cells (one oocyte and 15 
trophocytes) surrounded by an epithelial monolayer of 
somatic follicle cells (Figure 2A) [32]. We showed that 
the ectopic activation of AHR led to the degradation of 
egg chambers that is evident by the presence of pyknotic 
nuclei (Figure 2B). The follicular cell layer was often 
disorganized (Figure 2C). In some instances, we detected 
cysts with 32 trophocytes suggesting that AHR activation 
Figure 1: Phenotypic effects of endogenous and exogenous ligands of the human AHR on Drosophila growth and 
morphogenesis. (A) Ubiquitous expression of UAS-AhR leads to developmental lethality. The majority of tub>AhR animals die at the 
embryonic stage, with very few escapers that die at early larval stages, showing arrest in growth and development. Two four-day old larvae 
are shown, the larger one is the control (UAS-AhR/+; UAS-GFP/+, yellow arrow), the smaller green larva (red arrow) is tub>AhR, with 
ubiquitous expression of transgenic AHR (UAS-AhR/+; UAS-GFP/Tub-GAL4). The expression pattern of tub-GAL4 is visualized by GFP 
expression (green). (B–C). Drosophila leg phenotypes of Dll>AhR flies. (B) control (UAS-AhR/+). (C) Dll>AhR (Dll-GAL4/UAS-AhR). 
Flies developed on standard medium with no exogenous ligands. (D–I). Drosophila leg (D–F) and wing (G–I) phenotypes of dpp>AhR 
flies. (G) control (UAS-AhR/+). (D–F, H–I) dpp>AhR (dpp-GAL4/UAS-AhR). Flies developed on standard medium without exogenous 
ligands (G–H) or with indirubin (D), indinol (E, I) and beta-Naphthoflavone (F). At least 80 legs, 40 wings and more than 20 flies were 
analyzed for each genotype. Leg segments are indicated. Note the loss of tarsal segments in (C–D).
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led to an extra round of mitosis during cyst formation 
(Figure 2D). 
Next, we examined UAS-AhR expression in the 
larval nervous system using an Elav-GAL4 driver. The 
induction of UAS-AhR expression in the absence of the 
exogenous ligands did not affect the morphology of the 
Drosophila larval nervous system (Figure 2E). However, 
exposure of the UAS-AhR/Elav-GAL4 larvae to the 
exogenous ligands resulted in a smaller brain size and in a 
shorter ventral nerve cord (Figure 2F), suggesting that the 
activation of human AHR in tissues of the nervous system 
could hinder their growth and development.
We also examined eye phenotypes of the flies with 
induced UAS-AhR expression in the eye imaginal disks 
using the GMR-GAL4 driver. When the GMR-GAL4/
UAS-AhR flies were raised on standard medium with no 
exogenous ligands, no defects in eye development were 
detected: the ommatidia, i.e., the optical units that make 
up a compound adult fly eye, as well as microchaetae 
(mechanoreceptors), were packed in a regular array 
(Figure 3A–3A′). However, the exposure of the GMR-
GAL4/UAS-AhR larvae to the exogenous ligands resulted 
in a roughened eye phenotype of imagoes (Figure 3B–
3B′, Figure 3C–3C′, Figure 3D–3D′). A morphologically 
similar eye phenotype was observed in flies with dioxin-
mediated expression of mouse AHR induced by the GMR-
GAL4 driver [31]. It is worth noting that the magnitude 
of the eye defects varies depending on the ligand used: 
Figure 2: Activation of AHR in germline and nervous systems causes different abnormalities during Drosophila 
oogenesis and neurogenesis. (A–D) Confocal sections of the normal ovariole of MTD-GAL4/UAS-AhR female reared on standard 
medium (A); degraded egg chamber of MTD-GAL4/UAS-AhR female fed with beta-Naphthoflavone (arrows point on picnotic nuclei) (B); 
egg chamber with disordered follicular layer (arrow) from MTD-GAL4/UAS-AhR female reared on medium with indinol (C); follicle with 
32 trophocytes (arrow) from MTD-GAL4/UAS-AhR female fed with indirubin (D). Ovaries were stained with SytoxGreen (green) for DNA 
visualization and Phalloidin (red) for cytoskeleton visualization. Asterisks, T and FC indicate oocytes, trophocytes, and follicular cells, 
respectively. (E–F). Confocal sections of the central nervous system of UAS-mCD8-GFP; UAS-AhR/+; Elav-GAL4/+ larvae merged into 
a single 3D-image. Brains of late third instar larvae developed on standard medium (E) or on the medium containing beta-Naphthoflavone 
(F). Control brain (E) is significantly bigger than the brain with AhR expression (F). Elav-GAL4 (green, visualized by GFP expression) 
drives pan-neuronal expression of transgenic UAS-AhR in brain hemispheres (Br) and the ventral nerve cord (VNC). Magnification scale 
bars represent 100 μm in A, E, F and 20 μm in B, C, D.
Figure 3: Drosophila eye phenotypes of GMR>AhR flies. Flies developed on standard medium without exogenous ligands 
(A, A′), on medium with indinol (B, B′), beta-Naphthoflavone (C, C′) or indirubin (D, D′). Ommatidia are arranged in a highly regular 
pattern in control flies (A–A′), while flies reared on medium with exogenous ligands develop roughened eye phenotypes with irregular 
pattern and decreased number of mechanoreceptors (B–D, B′–D′).
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GMR-GAL4/UAS-AhR flies reared on medium with 
indinol, demonstrated more severe abnormalities (Figure 
3B–3B′) than those reared on medium with indirubin or 
beta-Naphthoflavone (Figure 3C–3C′, Figure 3D–3D′). 
Together, these results demonstrate the existence of the 
endogenous ligand(s) that is/are capable of activating 
induced human AHR in certain Drosophila tissues. 
However, in other tissues, AHR can be activated only by 
exogenous ligands making Drosophila a valuable model 
to study the effects of xenobiotics in vivo, at an organism 
level.
The effects of endogenous and exogenous ligands 
on the AHR target gene expression in Drosophila
To assess the ability of xenobiotics to affect 
expression of the human AHR target genes in Drosophila 
tissues we carried out a preliminary examination to identify 
potential human AHR target genes in Drosophila. Based on 
our analysis and on previous studies in humans [33–35] we 
chose several putative Drosophila homologues of the human 
AHR targets genes. All selected Drosophila genes contained 
XRE-elements in their regulatory regions (Supplementary 
Table 1). This set of putative AHR target genes represents 
genes that participate in cell proliferation, differentiation, 
and toxic agent biodegradation (Supplementary Table 2).
The Dll-GAL4/UAS-AhR flies raised on the standard 
medium with no exogenous ligands demonstrated strong 
leg abnormalities (Figure 1C). Therefore, we chose these 
animals to examine the effects of endogenous AHR ligands 
on the expression of AHR target genes. Comparison of the 
levels of mRNA synthesis by RT-PCR in the leg imaginal 
discs of the UAS-AhR larvae with the Dll-GAL4/UAS-AhR 
larvae developed on the standard medium demonstrated an 
increase in the transcription levels of most of the examined 
AHR target genes confirming that the leg imaginal disc 
tissue may contain endogenous ligand(s) for AHR 
activation (Figure 4).
To assess the effects of xenobiotics in vivo we 
analyzed expression of the AHR target genes in ovaries 
of MTD-GAL4/UAS-AhR females fed with exogenous 
ligands for 2 days. In these experiments we used beta-
Naphthoflavone, indirubin and indole-3-carbinol (indinol) 
as the human AHR ligands. We found that, depending on 
the nature of the exogenous ligand, the induced human 
AHR had pleiotropic effects on its target genes. Activation 
of the human AHR by indirubin and beta-Naphthoflavone 
resulted in the activation of Cyp6g1 and the suppression of 
St6Gal and Myc genes. The activation of the human AHR 
by indinol resulted in the suppression of St6Gal and the 
activation of Myc, Cdc42, dl, Mgat1, and GstT4 (Table 1, 
Supplementary Figure 1).
When human AHR was induced in the central 
nervous system by the Elav-GAL4 driver in larvae 
developed on medium supplemented with indinol or 
beta-Naphthoflavone, the expression levels of almost 
all of the target genes significantly increased (Table 1, 
Supplementary Figure 2). The activation of human 
AHR by indirubin resulted in an increase in the levels of 
St6Gal, Cyp6g1, dl, Cdc42 and Rbf, but a decrease in the 
levels of Mgat1, GstT4, Rel and Jra genes. However, the 
induction of human AHR by the Elav-GAL4 driver in adult 
brain, combined with feeding with exogenous ligands, 
generated less pronounced effects on the expression of 
the AHR target genes. The expression of some genes was 
not affected by xenobiotics while the expression of other 
genes reduced (Table 1, Supplementary Figure 3).
The xenobiotic-mediated effect of human AHR 
activity in eye imaginal disks of GMR-GAL4/UAS-AhR 
larvae also resulted in three modes of the target gene 
response: an increase in the gene expression, a decrease, 
and several genes had no response to the AHR activity 
(Table 1, Supplementary Figure 4).
Together, our results suggest that while the 
endogenous Drosophila ligands of the human AHR 
mostly led to an increase in the expression of the AHR 
target genes (Figure 4), the effects of the xenobiotics are 
Figure 4: Activation of AHR target genes in leg imaginal discs of Dll>AhR larvae in the absence of exogenous ligands. 
mRNA levels in leg imaginal discs of Dll-GAL4/UAS-AhR larvae (red) was compared to control UAS-AhR/+ larvae (blue) developed in 
the same conditions. The relative level of mRNA expression was measured using real-time PCR. Data are shown as representative of 
two independent experiments. The error bars represent the measurement error. Asterisk means the significant change in gene expression 
compared to the control.
Oncotarget102939www.impactjournals.com/oncotarget
Table 1. Summarized results of real-time PCR experiments shown on Supplementary Figures 1–4
Gene Ligand Indirubin Beta-Naphthoflavone Indinol
Central nervous system of larvae (Elav-GAL4 driver)
Sox70 0 + +
St6Gal + + +
Mgat1 − + +
GstT4 − 0 +
Cyp6g1 + + +
Rel − + +
dl + + +
p53 0 + +
Myc 0 + +
dap 0 + +
Rbf + + +
Jra − + +
Cdc42 + + +
Adult brains (Elav-GAL4 driver)
Sox70 + + 0
St6Gal + 0 0
Mgat1 0 0 0
GstT4 + + 0
Cyp6g1 + + +
Rel + + +
dl 0 0 −
p53 0 0 −
Myc + 0 0
dap + 0 −
Rbf + + +
Jra 0 0 −
Cdc42 0 0 −
Ovaries (MTD-GAL4 driver)
Sox70 0 + +
St6Gal 0 0 −
Mgat1 0 − −
GstT4 + + 0
Cyp6g1 + + +
Rel − + −
dl 0 0 −
p53 + − 0
Myc − 0 −
dap + + 0
Rbf + 0 −
Jra + 0 0
Cdc42 0 0 +
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pleiotropic depending on the gene and tissue. We detected 
both increases, decreases and no effects on the expression 
of multiple target genes in four different tissues: eye 
imaginal disks, larval central nervous system, adult brain 
and adult ovaries (Table 1, Supplementary Figures 1–4). 
The most striking increases in the xenobiotic-driven gene 
expression were detected in the larval CNS and brain. 
Transcriptional regulation by AHR is mediated 
by the PcG of epigenetic chromatin modifiers
Upon observation of the striking effects of AHR 
and its exogenous ligands/xenobiotics on fly development 
we hypothesized that some AHR target genes may also 
be under regulation by other developmental regulator 
networks. In particular, we posed the question whether 
some AHR target genes are also under the control of 
other developmental regulators, such as the Polycomb 
group (PcG) of epigenetic factors, which regulate gene 
expression by modulating the chromatin structure. 
This may explain the detected pleiotropic effects of the 
human AHR ligands during development. To test this 
hypothesis, we performed experiments using mutant flies 
with one null-allele of Polycomb (Pc4), a gene which is 
the key member of the PcG of epigenetic regulators and a 
component of the PRC1 complex [36–38]. 
To examine this hypothesis we compared the levels of 
expression of the AHR target genes in the heads of wild-type 
and Pc4 mutant animals carrying the UAS-AhR transgene. 
To avoid the effect of the endogenous ligands, we induced 
the expression of the UAS-AhR transgene in eye imaginal 
discs (GMR-GAL4 driver), and we only chose genes for 
analysis whose transcription levels in eyes decreased in 
response to the addition of ligands (beta-Naphthoflavone and 
indirubin): Sox70, Mgat1, dl, p53, dаp, and Cdc42 (Table 1, 
Supplementary Figure 4B–4C) to the food medium. Indeed, 
we detected an increase in the transcription levels of the 
human AHR target genes in GMR-GAL4/UAS-AhR; Pc4/+ 
Eye imaginal discs (GMR-GAL4 driver)
Sox70 − 0 +
St6Gal + 0 +
Mgat1 − − 0
GstT4 0 0 +
Cyp6g1 0 0 0
Rel 0 + +
dl − 0 +
p53 0 − +
Myc − − +
dap − − 0
Rbf 0 0 +
Jra 0 − 0
Cdc42 − − 0
Figure 5: The increase of AHR target genes expression in heads of GMR-GAL4/UAS-AhR; Pc4/+ imagoes. Flies developed 
from larvae grown on medium with added indirubin (green), beta-Naphthoflavone (purple), or standard medium without additives 
(blue). mRNA levels were analyzed by real-time PCR in heads dissected from GMR-GAL4/UAS-AhR; Pc4/+ imagoes. Data are shown as 
representative of two independent experiments. The error bars represent the measurement error. Asterisk means the reliable change in gene 
expression compared to the control.
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mutants compared to GMR-GAL4/UAS-AhR flies with the 
wild-type Pc gene, both of which were grown on the medium 
with the exogenous ligands (Figure 5, Table 2).
Given the importance of chromatin modifiers in 
cancer and other disease [39–41], significant efforts are 
being made to develop small molecule inhibitors of these 
enzymes (epigenetic inhibitors) and some are already 
available. To confirm the above results for Pc mutant flies 
and to examine potential cumulative effects of epigenetic 
inhibitors and xenobiotics, we examined the effect of 
UNC1999, a specific inhibitor of another key member 
of the PcG family, E(z), the only H3K27me3 histone 
methyltrasferase and a member of the PRC2 complex, in 
flies [42]. In addition, we used belinostat, an inhibitor of 
histone deacetylases (HDACs). Both inhibitors led to a 
similar general decondensation of the chromatin structure 
and, as a result, gene activation. Interestingly, the using 
of both inhibitors led to the similar, albeit less robust, 
increase in the expression of the AHR target genes in 
the presence of both xenobiotics (Figure 6, Table 2). The 
Table 2. The depletion of epigenetic repressors activates AHR target genes expression
Gene 
symbol
Allele of Polycomb and added Inhibitor
Pc+ Pc− Pc+ + UNC1999 Pc+ + Belinostat
Ligand
Indirubin BNF Indirubin BNF Indirubin BNF Indirubin BNF
Sox70 – 0 + + + + + +
Mgat1 – – + + + + + +
dl – 0 + + + + + +
p53 0 – + + + + + +
dаp – – + + + + + +
Сdc42 – – + + + + + +
Summarized results of real-time PCR experiments shown on Supplementary Figures 4–6. “Pc+” column represents the 
results for selected genes from Supplementary Figure 4 with decreased or maintained mRNA expression. “Pc−”, “Pc+ + 
UNC1999” and “Pc+ + Belinostat” columns represent the results shown on Figure 5 (for “Pc−”) and Figure 6. «+», «–» and 
«0» mean the increasing expression, the decreasing expression and no effect, respectively. BNF, beta-Naphthoflavone.
Figure 6: The increase of AHR target genes expression in heads of GMR>AhR imagoes. Flies developed from larvae grown 
on medium with UNC1999 (A), Belinostat (B), and ligands, indirubin (IR, green) and beta-Naphthoflavone (BNF, purple), or standard 
medium without additives (blue). mRNA levels were analyzed by real-time PCR in heads dissected from GMR-GAL4/UAS-AhR imagoes. 
Data are shown as representative of two independent experiments. The error bars represent the measurement error. Asterisk means the 
reliable change in gene expression compared to the control.
Oncotarget102942www.impactjournals.com/oncotarget
results of these experiments suggest that in some tissues 
and during certain periods of Drosophila development 
many AHR target genes are at the same time regulated 
by the chromatin-based epigenetic mechanisms of 
transcriptional regulation.
DISCUSSION
Endogenous ligands activate human AHR in 
the Drosophila leg and wing imaginal discs and 
during embryogenesis
Our phenotypic analysis revealed that ectopic 
expression of human AHR in various Drosophila organs 
and tissues affected their development. Interestingly, in 
some tissues, the effect was detected in the absence of 
exogenous ligands, while in other tissues it occurred only 
in the presence of exogenous ligands/xenobiotics. For 
example, the induction of ectopic expression of UAS-AhR 
by the tub-GAL4, Act-GAL4, dpp-GAL4 and Dll-GAL4 
drivers, caused phenotypic effects in the absence of the 
exogenous AHR ligands. This suggests that endogenous 
ligands can activate the human AHR in the Drosophila 
embryo, as well as in the wing and leg imaginal discs. 
Further molecular analysis of the expression of the AHR 
target genes in the leg imaginal discs confirmed our 
conclusion: the transcription levels of the majority of 
these genes increased despite the absence of exogenous 
ligands capable of activating of AHR (Figure 4). Since 
Dll-GAL4 drives UAS-AhR expression in the tarsal cap and 
the proximal ring of the leg imaginal discs in a very small 
number of cells comparative to the remaining bulk of the 
disc cells [43], the observed increase in the transcription 
levels of the AHR target genes is likely to be quite 
high. This ability of the human AHR to respond to the 
endogenous invertebrate ligands indicates a conservation 
of the structural and functional features of the AhR gene 
during the evolution of eukaryotes.
It is important to note that both the Dll-GAL4 and 
dpp-GAL4 drivers activate UAS-mediated human AHR 
expression in the leg imaginal discs, but the phenotypic 
effects of human AHR activation by endogenous ligands 
(defective leg segmentation) were observed only in the 
UAS-AhR/+;Dll-GAL4/+ flies (Figure 1C). Since Dll-GAL4 
and dpp-GAL4 drivers have different expression patterns 
within the leg imaginal discs, this indicates that the effect of 
the endogenous ligands on AHR activity is not only tissue, 
but also cell-type specific. Accordingly, in tissues with no 
Drosophila endogenous ligands capable of activating the 
human AHR, its activation requires exogenous xenobiotics.
Using Drosophila as a model to assess function of 
the human AHR
To activate human AHR by exogenous ligands, 
we used only molecules which are known to act as 
agonists of this receptor, i.e. cause only an increase in 
the transcription levels of AHR target genes in mammals 
[35]. Unexpectedly, in addition to an increase, we found 
a decrease and also unchanged expression levels of the 
Drosophila AHR target genes. The range of changes in 
the levels of transcription was very wide and time and 
tissue-specific for each of the ligands used (Table 1). We 
found increases in the transcription levels from several 
percentage points in fully differentiated tissues up to 
several hundred folds in tissues with actively proliferating 
cells. The decrease in transcription was from a few percent 
to almost complete suppression (Supplementary Figures 
1–4). We concluded that the human AHR may have tissue- 
and cell-specific effects on its target genes and that these 
effects are diverse and depend on the nature of the ligands, 
target genes and on the developmental stage. Importantly, 
our work is the first to show that Drosophila may serve as 
an important model organism to assess complex pleitropic 
effects of xenobiotics on the activity of the human AHR. 
Transcriptional regulation by AHR is linked to 
developmental activities of epigenetic modulators 
of chromatin structure
It is possible that our inability to detect expected 
increases in the expression of some AHR target genes in 
particular tissues may reflect the tight chromatin architecture 
of the target gene regulatory regions. This tight chromatin 
may impede the accessibility of the DNA binding sites to 
the AHR/ARNT transcription complex. The condensed 
structure of nucleosomes is usually associated with particular 
modifications of nucleosomal histones, such as a lack of 
acetylated residues and the presence of methylated residues, 
particularly in H3K27me3. These condensed, repressive 
chromatin structures are the products of the activities of 
the HDACs and PcG complexes, PRC1 (containing Pc) 
and PRC2 (containing histone methyltrasferase E(z)). In 
concert, these protein complexes are involved in epigenetic 
gene silencing by condensing the structure of chromatin 
[44–48]. 
Indeed, we confirmed this hypothesis by showing that 
genetic depletion of Pc, inhibition of HDACs by belinostat, 
and inhibition of E(z) H3K27me3 activity by UNC1999 
leads to an increase in the expression of some AHR target 
genes using ectopic expression of the human AHR and 
some of its exogeneous ligands (Figures 5–6, Table 2). 
The importance of this study is that it presents 
Drosophila as a valid model organism to study the in vivo 
effects of xenobiotics, i.e. the ligands of the human AHR 
during development. This is facilitated by the limited 
effects of the endogenous ligands in this model organism. 
An additional advantage of this model is that it provides 
the ability to study the input of the epigenetic modifiers 
in the functioning of the human AHR in the context of 
the organism, where these factors were discovered and 
best studied during development. In recent years, the 
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effect of the exogenous AHR ligands on different types 
of cancer has been intensively studied. As a result, new 
anticancer agents were discovered and set into production 
[49, 50]. However, their effect is not selective and strongly 
depends on the type of tumor [49]. At the same time, many 
pharmaceutical companies are rapidly developing small 
molecule inhibitors of histone-modifying enzymes, such 
as UNC1999 or HDAC inhibitors, with the hope that they 
can also be used as anti-cancer drugs [51, 52]. Importantly, 
our studies provide the first result that may merge both 
approaches in vivo, in that we found that inhibition of 
the activities of the PcG genes can modulate the action 
of the AHR exogenous ligands. Our results imply that in 
treating disease conditions caused by xenobiotics, it is 
essential to consider the applications of different types of 
pharmaceutical agents, not only affecting the effects of 
xenobiotics, but also affecting enzymes which modulate 
transcription of common target genes through changes in 
chromatin structure.
MATERIALS AND METHODS
Fly Stocks, Rearing Conditions and Reagents
UAS-AhR strain with inducible human AhR gene 
expression was obtained in this study as described 
below. Wild type Oregon R, w1118 and GAL4-driver lines 
were obtained from the Bloomington Drosophila stock 
center. The following GAL4 lines were used to drive the 
expression of the UAS-AhR construct: for ubiquitous 
expression - tub-GAL4 (genotype: y1w*; P{tubP-GAL4}
LL7/TM3,Sb1Ser1) and Act-GAL4 (genotype: y1w*; 
P{Act5C-GAL4-w}E1/CyO); for expression in leg and 
wing imaginal disks - dpp-GAL4 (genotype: y1w67c23; 
P{dpp-GAL4.PS}6A/TM6,Tb1) and Dll-GAL4 (genotype: 
P{GawB}Dllmd23/CyO); in eye imaginal disks - GMR-
GAL4 (genotype: w*; P{GAL4-ninaE.GMR}12); in the 
central nervous systems - Elav-GAL4 (genotype: P{GawB}
elavC155, P{UAS-mCD8::GFP.L}Ptp4ELL4, P{hsFLP}1, 
w*/FM7c), in germ line cells - MTD-GAL4 (genotype: 
P{otu-GAL4::VP16.R}1, w*; P{GAL4-nos.NGT}40; 
P{GAL4::VP16-nos.UTR}CG6325MVD1). Pc4p1e5/TM6C 
and UAS-GFP lines are the gift from Dr. Maxim Erokhin 
(Institute of Gene Biology Russian Academy of Science).
In genetic experiments we used standard Formula 
4-24 medium (Carolina Biological Supply, USA). 
Following ligands were used: 2′Z-Indirubin (SML0280, 
Sigma-Aldrich, USA), beta-Naphthoflavone (A18543, 
Alfa Aesar, Thermo Fisher Scientific, UK), Indole-3-
Carbinol (indinol, Mirax Biopharma, Russia). Following 
inhibitors were used: UNC1999 (SML0778, Sigma-
Aldrich, USA), belinostat (PXD101, Sigma-Aldrich, 
USA). Ligands and inhibitors were diluted in solution 
according to the manufacturer’s protocol and added 
to the Formula 4-24 medium at a corresponding final 
concentration: beta-Naphthoflavone - 200 mkg/g medium, 
indirubin - 25 mkg/g medium, indole-3-carbinol - 10 mg/g 
medium, UNC1999 - 20 mkg/g medium, belinostat - 20 
mkg/g medium. 
Ligands and inhibitors were fed to imago or larval 
offspring obtained after crossing the GAL4-driver flies 
with UAS-AhR flies. Parents were kept on standard 
Formula 4-24 medium, and then the larval offspring of late 
2nd stage was selected for feeding experiments. Larvae 
and flies were kept at room temperature (25ºC). 
To obtain flies with GMR-GAL4/UAS-AhR; Pc4/+ 
genotype we crossed UAS-AhR; Pc4p1e5/TM6C females 
with GMR-GAL4/Cy0 males and flies without balancer 
chromosomes were further selected in the offspring. 
Generation of transgenic UAS-AhR flies
Homo sapiens AhR cDNA was taken from pCMV6-
XL4 construct obtained from OriGene Technologies, Inc., 
clone SC119159 (NM_001621.2). A 5 kb human cDNA 
was cloned into the Not I restriction site in the pUAST 
vector. The correct orientation of the insert was proven by 
sequencing. The resulting UAS-AhR plasmid construct was 
injected into the early-stage (w1118) embryos using standard 
technique for the P-element dependent transformation 
[53], and w+-positive transformants were selected by 
standard genetic methods to select Drosophila UAS-AhR 
transgenic line. The site of the UAS-AhR insertion was 
genetically mapped on the 2nd chromosome. 
The presence of the human UAS-AhR construct in 
Drosophila genome was confirmed by PCR using a pair 
of Ahr1f and Ahr1rev primers (Supplementary Figure 5A). 
Inverse PCR analysis revealed that only one copy of UAS-
AhR was inserted in 60Е11 cytological region between 
CG30424 and Rpl19 loci (40 bp upstream of unknown 
CG30424 and approximately 540 bp downstream of 
Rpl19). Proper UAS-mediated inducible expression of the 
human UAS-AhR transgene was confirmed by RT-PCR and 
Western blot analysis of progeny obtained from crossing 
of UAS-AhR and Elav-GAL4 flies, grown on the standard 
medium and the medium with indinol (Supplementary 
Figure 5B–5С). PCR, RT-PCR and Western blot analysis 
were performed according to standard protocols [54]. 
Tubulin was used as the control for normalization. 
Polyclonal rabbit antibody Anti-AHR was used in dilution 
1:1000 (PA5-29642, ThermoFisherScientific, USA). 
Mouse antibody Anti-Actin clone C4 was used in dilution 
1:1000 (MAB1501, Merck Millipore, USA). 
Real-time reverse-transcription PCR analysis
Flies/larvae/organs were frozen in liquid 
nitrogen and total RNA was extracted using RNAzol 
RT reagent (Sigma-Aldrich, USA) according to the 
manufacturer’s specifications. RNA Samples were 
treated with DNase (Turbo DNA-free kit, Applied 
BioSystems, Life Technologies, USA) according to 
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the manufacturer’s protocol to remove genomic DNA 
contamination. cDNA was synthesized from 1–5 µg of 
total RNA, using a cDNA synthesis kit with oligo-dT 
priming (Thermo Fisher Scientific, USA). The levels 
of mRNA expression were measured with Real-Time 
Quantitative Reverse Transcription PCR using TaqMan® 
probes (Syntol, Russia). All reactions were carried out 
in triplicate. Real-time PCR was conducted using an 
ABI Prism 7500 Sequence Detection System (Applied 
BioSystems, Life Technologies, USA). The 2-ΔΔCt 
method was chosen as the calculation method [55]. The 
difference in the cycle threshold (Ct) value of the target 
gene and its housekeeping gene (Rpl32) called ΔCt was 
calculated using the following equation: ΔΔCt = (ΔCt 
of ligand treated flies) – (ΔCt of the untreated control 
flies). Sequences of primer pairs and TaqMan® probes are 
summarized in Supplementary Table 3. 
Immunohistochemistry
Ovaries were dissected in PBS and fixed for 
15 min in 4% paraformaldehyde in PBS + 0.2% 
Triton X-100. Following fixation, samples were 
rinsed 3 times with PBS + 0.2% Triton X-100, 
incubated for 1 hr in CF594 Phalloidin (Biotium, 1:40 
dilution), then rinsed 3 times in PBS. Ovaries were 
incubated for 15 min in RNase A (100 mg/ml), 
and rinsed again 3 times with PBS and incubated for 
15 min in SytoxGreen (Thermo Fisher Scientific, 1:500 
dilution), washed with PBS, and mounted in Vectashield 
mounting medium (H-1000, Vector laboratories).
For preparation and examination of larval CNS, the 
3rd instar larvae were immediately washed with ice cold 
PBS and kept on ice until dissection. Dissected larval CNS 
were fixed in 4% paraformaldehyde in PBS for 20 min, 
washed three times in PBS and mounted in Vectashield 
mounting medium (H-1000, Vector laboratories). GFP was 
visualized without staining. 
Microscopic analysis
Cuticle preparations of legs and wings were made as 
described previously [56] and examined using Olympus 
AH-2 Vanox light microscope. Eyes were scanned with 
Keyence VHX-1000E digital microscope. Preparations of 
ovaries and larval CNS were examined using Leica TCS 
SP5 confocal microscope.
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